Similar Posts
Critics Wonder Whether the FDA Is Too Slow to Handle a Pandemic
The FDA plays a critical role in our nation’s response to the COVID-19 pandemic. It helps decide which medicines are safe and effective to treat the disease. It evaluates the accuracy and reliability of laboratory tests. And it will play a central role in assessing potential vaccines. But will the FDA bureaucracy move with the…
Science Isn’t Meant To Be Followed
Science cannot lead us out of this pandemic. Whatever paths we take to navigate COVID-19 need to be chosen through political processes. The true role of science is to illuminate these pathways, guiding our policy choices by showing us what’s at stake.
Work Requirements For Safety Net Programs – They’re Not Working
Anyone who has raised kids knows what happens when you give them a monthly allowance without requiring any work in return: they plop in front of their new videogame consoles while their dirty dishes collect in the sink. That’s the logic behind Republican plans to establish work requirements for people who receive safety net benefits—if…
Pandemics and Overdoses: COVID-19 May Worsen Our Opioid Epidemic
The novel coronavirus has decimated our economy at the same time as it has directly threatened our health. As if that weren’t bad enough, the economic damage Covid-19 is causing could have an indirect impact on our health. Consider what we already know about economic downturns and opioid overdoses. A research team led by Atheendar…
Drugs Are Outrageously Expensive—Canada Found A Way To Fight Back
Latuda is a drug to treat schizophrenia. It costs about $4,000 per month in the U.S. In Canada, the price is closer to $500.
Ibrance, a breast cancer drug, costs $10,000 more per month in the U.S. than in Canada.
Why these enormous price differences?
